Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: enGene Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
enGene Therapeutics Inc. June 10, 202586.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 28, 2024 | enGene Therapeutics Inc. | Option exercise | +120 | $0.89 | $107 |
| Oct 31, 2023 | enGene Therapeutics Inc. | Grant or award | +24,555 | — | — |
Questions about Richard M. Glickman
What boards is Richard M. Glickman on?
Richard M. Glickman sits on the board of enGene Therapeutics Inc.
How long has Richard M. Glickman served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.